Sponsor Pipeline

Anthos Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05712200 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial… Atrial Fibrillation (AF) Recruiting
Phase 2
NCT04755283 Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial… Atrial Fibrillation (AF) Active, Not Recruiting
Disease Areas
Atrial Fibrillation (2) Stroke (1)
Get alerts when Anthos Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free